About
Founded in 1985, Gemini Bio is a supplier of cell culture media, sera, and other reagents and instruments to many of the top research and academic institutions as well as biotechnology, cell/gene therapy, and pharmaceutical companies. Gemini Bioproducts, LLC, is a portfolio company of BelHealth Investment Partners, LLC, a New York-based healthcare private equity firm. Gemini Bio, which operates in West Sacramento, California, is growth-focused and is expanding and enhancing its manufacturing capabilities driving toward higher quality and compliance standards commensurate with the needs of the commercial therapeutic space. Gemini Bio is augmenting its product portfolio through acquisitions, internal innovation, and partnerships.